Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

NCT00720447 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: alemtuzumab
BIOLOGICAL: donor lymphocytes
DRUG: carmustine
DRUG: cytarabine
DRUG: etoposide
DRUG: melphalan
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Cancer Research UK